JWL-27773-06813
4 vaccinations
7 coded responses
40 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 840 / UT
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Moderna
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-19
- 2021-01-26
-
2021-02-02
Dose 2 — Moderna
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-02-04
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node in neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
-
2021-02-23
Survey response — day 21, dose 2MedDRA: Headache — Feeling: GoodFree text: Headaches 5/7 days of the weekMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
- 2021-08-03
-
2021-11-01
Dose 3 — Moderna
- 2022-02-02
- 2022-05-02
-
2022-10-16
Dose 4 — Pfizer-BioNTech
-
2022-10-17
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Itching · Headache, Fatigue or tirednessFree text: Swollen lymph node in neckMedDRA releases: 2024-11 · check-in free text available
-
2022-10-18
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, ItchingFree text: Swollen lymph node in neckMedDRA releases: 2024-11 · check-in free text available
-
2022-10-19
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node in neckMedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node in neckMedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
- 2022-10-22
- 2022-10-30
- 2022-11-06
- 2022-11-15
- 2022-11-20
-
2022-11-27
Survey response — day 42, dose 4MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend schoolFree text: Upper respiratory tract infectionMedDRA releases: 2024-11 · check-in free text available
- 2023-01-15
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-02 | Moderna | |
| 3 | 2021-11-01 | Moderna | No |
| 4 | 2022-10-16 | Pfizer-BioNTech | No |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph node in neck
Release 4 — day 21, dose 2
Symptoms: Headaches 5/7 days of the week
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Swollen lymph node in neck
Systemic reaction (other): Swollen lymph node in neck
Systemic reaction (other): Swollen lymph node in neck
Systemic reaction (other): Swollen lymph node in neck
Release 12 — day 42, dose 4
Symptoms: Upper respiratory tract infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release